FDA label
What is repaglinide used for?
The FDA-approved uses of repaglinide, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted repaglinide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Repaglinide, tablet
Indications and Usage, quoted from the label by Rising Pharma Holdings, Inc. (ANDA203820). Cross-references to other label sections are left out.
Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Source: DailyMed label, set id d7673e22-0dbb-4395-ad60-943d249203a1, version 7, effective May 14, 2024. NDC 57237-157, one of 20 listings for this product.
Questions
What is repaglinide used for?
The FDA label says: “Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.”
What drug class is repaglinide?
FDA lists repaglinide in the Glinide established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.